| Mrs Jennifer Abillar-wright, FNP-BC | |
|
225 Summit Ave, Montvale, NJ 07645-1523 | |
| (201) 775-7513 | |
| (201) 691-6661 |
| Full Name | Mrs Jennifer Abillar-wright |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 225 Summit Ave, Montvale, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841897824 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Msk Bergen | 1456614114 | 132 |
News Archive
Researchers of the Catalan Institute of Oncology (ICO) at the Bellvitge Biomedical Research Institute (IDIBELL) have developed and validated a new method to diagnose hereditary breast and ovarian cancer syndrome based on mass sequencing of BRCA1 and BRCA2 genes. The model is based on a genetic and bioinformatic analysis which has been proved very effective.
A molecule which can stop the formation of long protein strands, known as amyloid fibrils, that cause joint pain in kidney dialysis patients has been identified by researchers at the University of Leeds.
The Wall Street Journal reports on the recent shutdown of a counterfeit drug ring in Syria, while highlighting a broader problem with counterfeit medicines in the Middle East. Authorities intercepted "millions of dollars worth of breast cancer, leukemia and other medicines … At least 65 people were detained; it couldn't be learned if they were charged. A trial date hasn't yet been set," according to the newspaper, which notes that the drug ring distributor's activities had also penetrated into some public health systems, "particularly in Iraq."
An academic team which includes key researchers from the Universities of Manchester and Hull has taken both first and second prizes, in a nationwide innovation competition run by Microsoft.
Drew Armstrong, a Congressional Quarterly staff reporter, discusses the latest developments in efforts to overhaul the U.S. health care system, legislation that would give FDA regulatory authority over tobacco products and a new bill that would allow FDA to approve generic versions of biotechnology drugs in this week's "Health on the Hill from kaisernetwork.org and CQ."
› Verified 5 days ago
| Entity Name | Memorial Sloan Kettering Cancer Center At Basking Ridge New Jersey |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184637886 PECOS PAC ID: 0143229534 Enrollment ID: O20061213000044 |
News Archive
Researchers of the Catalan Institute of Oncology (ICO) at the Bellvitge Biomedical Research Institute (IDIBELL) have developed and validated a new method to diagnose hereditary breast and ovarian cancer syndrome based on mass sequencing of BRCA1 and BRCA2 genes. The model is based on a genetic and bioinformatic analysis which has been proved very effective.
A molecule which can stop the formation of long protein strands, known as amyloid fibrils, that cause joint pain in kidney dialysis patients has been identified by researchers at the University of Leeds.
The Wall Street Journal reports on the recent shutdown of a counterfeit drug ring in Syria, while highlighting a broader problem with counterfeit medicines in the Middle East. Authorities intercepted "millions of dollars worth of breast cancer, leukemia and other medicines … At least 65 people were detained; it couldn't be learned if they were charged. A trial date hasn't yet been set," according to the newspaper, which notes that the drug ring distributor's activities had also penetrated into some public health systems, "particularly in Iraq."
An academic team which includes key researchers from the Universities of Manchester and Hull has taken both first and second prizes, in a nationwide innovation competition run by Microsoft.
Drew Armstrong, a Congressional Quarterly staff reporter, discusses the latest developments in efforts to overhaul the U.S. health care system, legislation that would give FDA regulatory authority over tobacco products and a new bill that would allow FDA to approve generic versions of biotechnology drugs in this week's "Health on the Hill from kaisernetwork.org and CQ."
› Verified 5 days ago
| Entity Name | Msk Bergen |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558814657 PECOS PAC ID: 1456614114 Enrollment ID: O20180410002157 |
News Archive
Researchers of the Catalan Institute of Oncology (ICO) at the Bellvitge Biomedical Research Institute (IDIBELL) have developed and validated a new method to diagnose hereditary breast and ovarian cancer syndrome based on mass sequencing of BRCA1 and BRCA2 genes. The model is based on a genetic and bioinformatic analysis which has been proved very effective.
A molecule which can stop the formation of long protein strands, known as amyloid fibrils, that cause joint pain in kidney dialysis patients has been identified by researchers at the University of Leeds.
The Wall Street Journal reports on the recent shutdown of a counterfeit drug ring in Syria, while highlighting a broader problem with counterfeit medicines in the Middle East. Authorities intercepted "millions of dollars worth of breast cancer, leukemia and other medicines … At least 65 people were detained; it couldn't be learned if they were charged. A trial date hasn't yet been set," according to the newspaper, which notes that the drug ring distributor's activities had also penetrated into some public health systems, "particularly in Iraq."
An academic team which includes key researchers from the Universities of Manchester and Hull has taken both first and second prizes, in a nationwide innovation competition run by Microsoft.
Drew Armstrong, a Congressional Quarterly staff reporter, discusses the latest developments in efforts to overhaul the U.S. health care system, legislation that would give FDA regulatory authority over tobacco products and a new bill that would allow FDA to approve generic versions of biotechnology drugs in this week's "Health on the Hill from kaisernetwork.org and CQ."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jennifer Abillar-wright, FNP-BC 63 Hamilton Ave, Tappan, NY 10983-1002 Ph: (845) 300-1371 | Mrs Jennifer Abillar-wright, FNP-BC 225 Summit Ave, Montvale, NJ 07645-1523 Ph: (201) 775-7513 |
News Archive
Researchers of the Catalan Institute of Oncology (ICO) at the Bellvitge Biomedical Research Institute (IDIBELL) have developed and validated a new method to diagnose hereditary breast and ovarian cancer syndrome based on mass sequencing of BRCA1 and BRCA2 genes. The model is based on a genetic and bioinformatic analysis which has been proved very effective.
A molecule which can stop the formation of long protein strands, known as amyloid fibrils, that cause joint pain in kidney dialysis patients has been identified by researchers at the University of Leeds.
The Wall Street Journal reports on the recent shutdown of a counterfeit drug ring in Syria, while highlighting a broader problem with counterfeit medicines in the Middle East. Authorities intercepted "millions of dollars worth of breast cancer, leukemia and other medicines … At least 65 people were detained; it couldn't be learned if they were charged. A trial date hasn't yet been set," according to the newspaper, which notes that the drug ring distributor's activities had also penetrated into some public health systems, "particularly in Iraq."
An academic team which includes key researchers from the Universities of Manchester and Hull has taken both first and second prizes, in a nationwide innovation competition run by Microsoft.
Drew Armstrong, a Congressional Quarterly staff reporter, discusses the latest developments in efforts to overhaul the U.S. health care system, legislation that would give FDA regulatory authority over tobacco products and a new bill that would allow FDA to approve generic versions of biotechnology drugs in this week's "Health on the Hill from kaisernetwork.org and CQ."
› Verified 5 days ago
Sally Aboelela, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 22 Summit Ave, Montvale, NJ 07645 Phone: 201-693-0411 | |
Patricia A Cavanna, RNFA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2a Sweeney Ct, Montvale, NJ 07645 Phone: 201-410-6179 | |
Mrs. Janet Borrello Peppard, APN, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 135 Chestnut Ridge Road Suite 1120, Montvale, NJ 07645 Phone: 201-391-2020 |